Azithromycin versus comparative therapy for the treatment of community acquired pneumonia

Galia Rahav, Joseph Fidel, Yair Gibor, Mervyn Shapiro

Research output: Contribution to journalArticlepeer-review

Abstract

A 3-day course of azithromycin was compared with the 10 days of other antibiotics, which general practitioners routinely use as therapy for community acquired pneumonia (CAP). The study was a prospective open labelled, randomised, multicentre, comparative study from five family clinics. Patients with clinical and radiological evidence of pneumonia were included. The pneumonia resolved in 98.4% (61/62) of patients treated with azithromycin and in 87% (40/46) of patients treated with other antibiotics (P<0.017). Restitution of normal function at home (2.3±1.2 and 4.3±2.6 days) and return to work (3.4±2.0 and 5.5±3.1 days) was more rapid among the group treated with azithromycin (P<0.001). Three days of azithromycin was more convenient and cost effective than the comparators used to treat pneumonia.

Original languageEnglish
Pages (from-to)181-184
Number of pages4
JournalInternational Journal of Antimicrobial Agents
Volume24
Issue number2
DOIs
StatePublished - Aug 2004
Externally publishedYes

Keywords

  • Azithromycin
  • Community acquired pneumonia

Fingerprint

Dive into the research topics of 'Azithromycin versus comparative therapy for the treatment of community acquired pneumonia'. Together they form a unique fingerprint.

Cite this